# Multicenter Study of the Safety and Efficacy of NAFT-500 in Tinea Cruris

> **NCT00750152** · PHASE3 · COMPLETED · sponsor: **Merz North America, Inc.** · enrollment: 334 (actual)

## Conditions studied

- Tinea Cruris
- Jock Itch

## Interventions

- **DRUG:** NAFT-500
- **DRUG:** Placebo

## Key facts

- **NCT ID:** NCT00750152
- **Lead sponsor:** Merz North America, Inc.
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE3
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2008-09
- **Primary completion:** 2009-08
- **Final completion:** 2010-02
- **Target enrollment:** 334 (ACTUAL)
- **Last updated:** 2013-04-22


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00750152

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00750152, "Multicenter Study of the Safety and Efficacy of NAFT-500 in Tinea Cruris". Retrieved via AI Analytics 2026-08-03 from https://api.ai-analytics.org/clinical/NCT00750152. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*